Lead and manage internal chemistry resources and CRO teams to identify IND-ready candidate molecules.
Serve as chemistry leader within multidisciplinary project teams, building effective relationships across geographically dispersed collaborators.
Use SAR analysis and computational tools to design novel molecules and establish intellectual property.
Centessa Pharmaceuticals is a clinical-stage company developing orexin receptor 2 (OX2R) agonists as a new class of medicines for the treatment of narcolepsy and potentially other sleep-wake disorders. Headquartered in Boston, Massachusetts, it was recognized as a Great Place to Work in 2026.
Define and drive asset strategy for small molecule clinical programs in oncology and immunology/inflammation, integrating competitive positioning and biomarker strategy.
Translate Recursion OS and ClinTech insights into strategic advantages, ensuring proprietary data and computational insights maximally enable drug discovery and development.
Partner with functional leaders across clinical development, BD, finance, and platform teams to align resource allocation with strategic conviction and impact.
Recursion is a clinical-stage TechBio company decoding biology to improve lives, advancing a pipeline of investigational medicines across oncology, rare disease, neuroscience, and immunology. The company uses its AI-native Recursion OS platform and employs a team fluent in both science and AI, with offices in Salt Lake City, Oxfordshire, New York, Montréal, and London.